Clinical trials
Active, not recruiting Hyperlipidemias trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 2 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 4 |
| 2025 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2 |
| NewAmsterdam Pharma | 2 |
| Brigham and Women's Hospital | 1 |
| Corsera Health | 1 |
| Daewoong Pharmaceutical Co. LTD. | 1 |
| Duke University | 1 |
| Fujian Shengdi Pharmaceutical Co., Ltd. | 1 |
| Johns Hopkins University | 1 |
| Madrigal Pharmaceuticals, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperlipidemias | 21 |
| Dyslipidemias | 5 |
| Hypertension | 5 |
| Diabetes Mellitus, Type 2 | 4 |
| Hypercholesterolemia | 4 |
| Obesity | 4 |
| Atherosclerosis | 3 |
| Cardiovascular Diseases | 3 |
| Diabetes Mellitus | 3 |
| Overweight | 3 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.